Challenges in RCC Imaging: Renal Insufficiency, Post-Operative Surveillance, and the Role of Radiomics
- PMID: 26937265
- PMCID: PMC4770557
Challenges in RCC Imaging: Renal Insufficiency, Post-Operative Surveillance, and the Role of Radiomics
Keywords: Renal cell carcinoma imaging; diffusion MRI; kidney cancer surveillance; molecular imaging; perfusion MRI; radiation exposure.
Figures


Similar articles
-
Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.Int Urol Nephrol. 2017 Feb;49(2):215-224. doi: 10.1007/s11255-016-1460-3. Epub 2016 Nov 16. Int Urol Nephrol. 2017. PMID: 27853915
-
Metastatic Renal Cell Carcinoma Masquerading as Jugular Foramen Paraganglioma: A Role for Novel Magnetic Resonance Imaging.Ann Otol Rhinol Laryngol. 2017 Aug;126(8):606-610. doi: 10.1177/0003489417714487. Epub 2017 Jun 10. Ann Otol Rhinol Laryngol. 2017. PMID: 28602102
-
Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols?BJU Int. 2013 May;111(6):891-6. doi: 10.1111/j.1464-410X.2012.11531.x. Epub 2013 Jan 18. BJU Int. 2013. PMID: 23331317 Review.
-
Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI.Int Urol Nephrol. 2018 Feb;50(2):197-204. doi: 10.1007/s11255-017-1761-1. Epub 2017 Dec 11. Int Urol Nephrol. 2018. PMID: 29230706
-
Imaging of renal cell carcinoma.Urol Oncol. 2016 Mar;34(3):147-55. doi: 10.1016/j.urolonc.2015.05.020. Epub 2015 Jun 18. Urol Oncol. 2016. PMID: 26094171 Review.
Cited by
-
Renal cell carcinoma: the search for a reliable biomarker.Transl Cancer Res. 2017 Jun;6(3):620-632. doi: 10.21037/tcr.2017.05.19. Transl Cancer Res. 2017. PMID: 28775935 Free PMC article.
-
Precision Oncology: Identifying Predictive Biomarkers for the Treatment of Metastatic Renal Cell Carcinoma.Transl Cancer Res. 2016 Jun;5(Suppl 1):S76-S80. doi: 10.21037/tcr.2016.06.05. Transl Cancer Res. 2016. PMID: 27540511 Free PMC article.
-
EphA4 protein promotes invasion in clear cell renal cell carcinomas.Int J Clin Exp Pathol. 2017 Dec 1;10(12):11737-11742. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966534 Free PMC article.
-
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?Future Oncol. 2019 May;15(15):1683-1695. doi: 10.2217/fon-2018-0951. Epub 2019 Apr 10. Future Oncol. 2019. PMID: 30968729 Free PMC article. Clinical Trial.
-
Metachronous Renal Cell Carcinoma: A Rare Presentation of Adrenal Crisis.Cureus. 2021 Jun 27;13(6):e15965. doi: 10.7759/cureus.15965. eCollection 2021 Jun. Cureus. 2021. PMID: 34235028 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: a cancer journal for clinicians. 2015 Jan-Feb;65(1):5–29. - PubMed
-
- Chow WH, Devesa SS, Warren JL, Fraumeni JF., Jr. Rising incidence of renal cell cancer in the United States. Jama. 1999 May 5;281(17):1628–1631. - PubMed
-
- Media ACoDaC. ACR Manual on Contrast Media. 10.1 ed2015:33-44
-
- Elicker BM, Cypel YS, Weinreb JC. IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy. AJR. American journal of roentgenology. 2006 Jun;186(6):1651–1658. - PubMed
-
- Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clinical journal of the American Society of Nephrology : CJASN. 2008 Jan;3(1):273–280. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources